Previous study has demonstrated that treatment with antibiotics (e.g., polymyxin B) targeting gram-negative bacteria efficiently reduced tumor necrosis factor (TNF) production and plasma LPS levels, leading to the reversal of hepatic steatosis [7]. This evidence concerns the gene TNF and fatty liver disease.